TD 500

Testosterone Enanthate / Nandrolone Decanoate Injection

PRODUCT NAME & PACKAGING

Brand Name: TD 500
Generic Name: Testosterone Enanthate + Nandrolone Decanoate
Strength & Packaging: 10 mL multidose vial | 250 mg/mL Testosterone Enanthate + 250 mg/mL Nandrolone Decanoate
Total concentration: 500 mg/mL

This presentation is a fixed-dose injectable blend combining two long-acting esterified androgen/anabolic agents in an oil-based multidose vial. Testosterone enanthate and nandrolone decanoate are both described in U.S. labeling as intramuscular injectable products.

DESCRIPTION

TD 500 is a concentrated injectable combination of testosterone enanthate and nandrolone decanoate. Testosterone enanthate is an androgen ester used in labeled products for testosterone replacement, while nandrolone decanoate is an anabolic steroid preparation described in public labeling as a sterile oleaginous solution. For catalog purposes, this product is best described as a manufacturer-specific fixed-dose injectable blend rather than a standard FDA-labeled combination product.

INDICATIONS

The two active ingredients have different labeled reference uses: testosterone enanthate is indicated in labeled products for replacement therapy in conditions associated with deficiency or absence of endogenous testosterone, while nandrolone decanoate is indicated in labeled products for the management of anemia of renal insufficiency. Because this exact fixed-dose combination was not identified as a standard labeled product in the sources reviewed, use should follow the specific manufacturer’s labeling, local regulations, and licensed-prescriber judgment.

DOSAGE & ADMINISTRATION

Route: Intramuscular injection

For a medical-reference catalog entry, the safest professional wording is:
“Administer only under the direction of a licensed healthcare professional. Dosage should be individualized according to the manufacturer’s labeling, therapeutic response, and benefit-risk assessment.”

Both reference products are injectable formulations, and the nandrolone decanoate label specifically states it is intended for deep intramuscular injection, preferably into the gluteal muscle. Parenteral products should be visually inspected for particulate matter and discoloration before administration whenever the solution and container permit.

PRECAUTIONS

Use requires careful professional oversight. Public testosterone labeling warns of risks including venous thromboembolic events, possible cardiovascular risk concerns, prostatic effects, and blood pressure increases with testosterone products. Public nandrolone labeling warns about virilization, edema, adverse lipid changes, potential hepatic complications, and lack of safety or effectiveness for enhancement of athletic performance. Both agents are unsuitable in pregnancy because androgen exposure may masculinize the fetus.

SIDE EFFECTS

Potential adverse effects associated with the reference components include acne, gynecomastia, edema, changes in libido, nausea, vomiting, insomnia, depression, and androgenic or virilizing effects such as deepening of the voice, hirsutism, and menstrual irregularities. Testosterone labeling also highlights risks such as venous thromboembolism, while nandrolone labeling notes possible testicular suppression, lipid changes, and hepatic adverse events with long-term anabolic steroid exposure.

STORAGE

Store according to the finished product labeling. Reference labels for the two components support controlled room temperature storage at 20°C to 25°C (68°F to 77°F). Nandrolone decanoate labeling also specifies protection from light and storage in the carton until contents are used, while testosterone enanthate labeling notes that crystals formed at low temperatures may re-dissolve when the vial is warmed and rotated between the palms.